These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 9816036)

  • 21. Immunogenicity of human melanoma-associated antigens defined by murine monoclonal antibodies in allogeneic and xenogeneic hosts.
    Hamby CV; Liao SK; Kanamaru T; Ferrone S
    Cancer Res; 1987 Oct; 47(20):5284-9. PubMed ID: 3115563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
    Temponi M; Gold AM; Ferrone S
    Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of anti HMW.MAA antibodies in sera of melanoma patients using antiidiotypic monoclonal antibodies].
    Nakamura T; Kageshita T; Arao T; Yamazaki N; Ishihara K
    Nihon Hifuka Gakkai Zasshi; 1990 Oct; 100(11):1121-6. PubMed ID: 2273574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.
    Mittelman A; Chen ZJ; Kageshita T; Yang H; Yamada M; Baskind P; Goldberg N; Puccio C; Ahmed T; Arlin Z
    J Clin Invest; 1990 Dec; 86(6):2136-44. PubMed ID: 2254463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants.
    Giacomini P; Natali P; Ferrone S
    J Immunol; 1985 Jul; 135(1):696-702. PubMed ID: 2582052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside.
    Chapman PB; Wu D; Ragupathi G; Lu S; Williams L; Hwu WJ; Johnson D; Livingston PO
    Clin Cancer Res; 2004 Jul; 10(14):4717-23. PubMed ID: 15269144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
    Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
    Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Level of a membrane-bound high-molecular-weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma.
    Giacomini P; Veglia F; Cordiali Fei P; Rehle T; Natali PG; Ferrone S
    Cancer Res; 1984 Mar; 44(3):1281-7. PubMed ID: 6692408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-reactivity of murine anti-human high molecular weight-melanoma associated antigen monoclonal antibodies with guinea pig melanoma cells.
    Liao SK; Smith JW; Kwong PC; Natali PG; Kusama M; Hamby CV; Ferrone S
    Cancer Res; 1987 Sep; 47(18):4835-41. PubMed ID: 3476198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between induction of anti high molecular weight-melanoma associated antigen (HMW-MAA) immunity with mouse antiidiotypic monoclonal antibody (MoAb) MK2-23 and prolongation of survival in patients with melanoma.
    Chen ZJ; Yang H; Liu CC; Mittelman A; Ferrone S
    Pigment Cell Res; 1992; Suppl 2():113-22. PubMed ID: 1409413
    [No Abstract]   [Full Text] [Related]  

  • 31. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plus BCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodies.
    Yao TJ; Meyers M; Livingston PO; Houghton AN; Chapman PB
    Clin Cancer Res; 1999 Jan; 5(1):77-81. PubMed ID: 9918205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved tumor targeting of rhenium-186-labeled anti-human high-m.w. melanoma-associated antigen monoclonal antibody 763.74 following purification with anti-idiotypic monoclonal antibody MK2-23.
    Hamby CV; Chinol M; Palestro CJ; Manzo C; Ferrone S
    Int J Cancer; 1998 Nov; 78(4):486-90. PubMed ID: 9797138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of human melanoma growth in nude mice injected with anti high-molecular-weight melanoma-associated antigen monoclonal antibody 225.28S conjugated to purothionin.
    Matsui M; Nakanishi T; Noguchi T; Imai K; Yachi A; Ferrone S
    Jpn J Cancer Res; 1985 Feb; 76(2):119-23. PubMed ID: 3920101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study.
    Chapman PB; Morrissey DM; Panageas KS; Hamilton WB; Zhan C; Destro AN; Williams L; Israel RJ; Livingston PO
    Clin Cancer Res; 2000 Mar; 6(3):874-9. PubMed ID: 10741710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of human melanoma tumor growth in severe combined immunodeficient mice by passive transfer of antibodies induced by a high molecular weight melanoma-associated antigen mimotope vaccine.
    Wagner S; Krepler C; Allwardt D; Latzka J; Strommer S; Scheiner O; Pehamberger H; Wiedermann U; Hafner C; Breiteneder H
    Clin Cancer Res; 2008 Dec; 14(24):8178-83. PubMed ID: 19088033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active specific immunization in the treatment of patients with melanoma.
    Mastrangelo MJ; Maguire HC; Sato T; Nathan FE; Berd D
    Semin Oncol; 1996 Dec; 23(6):773-81. PubMed ID: 8970602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
    Reinartz S; Hombach A; Köhler S; Schlebusch H; Wallwiener D; Abken H; Wagner U
    Cancer Res; 2003 Jun; 63(12):3234-40. PubMed ID: 12810653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight proteoglycan antigen.
    Pride MW; Shuey S; Grillo-Lopez A; Braslawsky G; Ross M; Legha SS; Eton O; Buzaid A; Ioannides C; Murray JL
    Clin Cancer Res; 1998 Oct; 4(10):2363-70. PubMed ID: 9796966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.